Carysil Q1 Results: Net Profit Rises to ₹310M, EBITDA Margin Expands to 20.4%

1 min read     Updated on 10 Aug 2026, 03:10 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Carysil Limited reported strong Q1 results with consolidated net profit rising to ₹310M from ₹230M year-on-year, revenue growing to ₹2.6B from ₹2.3B, and EBITDA increasing to ₹534M from ₹438M. The EBITDA margin expanded to 20.4% from 19.3%, reflecting improved operational efficiency. Results were discussed at an earnings call on August 11, 2026, hosted by Go India Advisors, featuring Chairman & MD Chirag Parekh and Group CFO Anand Sharma.

powered bylight_fuzz_icon
47476865

*this image is generated using AI for illustrative purposes only.

Carysil Limited has reported its financial results for the first quarter, posting a consolidated net profit of ₹310M compared to ₹230M in the same period last year, reflecting a robust year-on-year improvement. Revenue for the quarter came in at ₹2.6B versus ₹2.3B in the corresponding period, while EBITDA rose to ₹534M from ₹438M, with the EBITDA margin expanding to 20.4% from 19.3%. The results were discussed during an earnings conference call held on Tuesday, August 11, 2026, at 4:00 PM IST, hosted by Go India Advisors.

Q1 Financial Highlights

Carysil's quarterly performance reflects broad-based improvement across key financial metrics. The following table summarises the year-on-year comparison:

Metric: Q1 FY27 Q1 FY26 (YoY)
Revenue: ₹2.6B ₹2.3B
EBITDA: ₹534M ₹438M
EBITDA Margin: 20.4% 19.3%
Consolidated Net Profit: ₹310M ₹230M

Earnings Call Details

The earnings conference call featured key leadership from Carysil Limited. Mr. Chirag Parekh, Chairman and Managing Director, and Mr. Anand Sharma, Executive Director and Group CFO, addressed queries from analysts and investors following the presentation of the Q1 results. The call was hosted by Go India Advisors, and the audio recording and transcript are available on the company's website at https://carysil.com/ .

Participant Designation
Chirag Parekh Chairman & Managing Director
Anand Sharma Executive Director & Group CFO

Dial-In Information

The earnings call offered multiple access points for domestic and international participants, with universal dial-in numbers for India and toll-free numbers for the USA, UK, Singapore, and Hong Kong.

Region Contact Number
India (Universal) +91 22 6280 1557 / +91 22 7115 8383
USA (Toll Free) 1866 746 2133
UK (Toll Free) 0808 1011 573
Singapore (Toll Free) 800 101 2045
Hong Kong (Toll Free) 800 964 448

Contact Information

For further information or assistance regarding the earnings call, investors may contact the advisors at Go India Advisors:

The original earnings call announcement was signed by Reena Tejas Shah, Company Secretary and Compliance Officer, on August 05, 2026.

Historical Stock Returns for CARYSIL

1 Day5 Days1 Month6 Months1 Year5 Years
+5.73%+6.50%+11.93%+32.06%+57.66%+92.94%

What specific operational strategies or cost-control measures drove the expansion of EBITDA margins from 19.3% to 20.4% in Q1 FY27?

How does management plan to sustain this revenue growth trajectory given the current competitive landscape in the specialty chemicals sector?

Are there any upcoming capital expenditure plans or capacity expansions announced during the call that could impact future cash flows?

Carysil Ltd pays ₹1.44 lakh for FEMA reporting delay

2 min read     Updated on 08 Jul 2026, 07:40 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Carysil Limited disclosed that the RBI levied a compounding fee of ₹1,44,000 for a delay in reporting a subsidiary's overseas investment. The order under FEMA, 1999, cited a contravention of reporting regulations but confirmed no material impact on the company's operations beyond the payment.

powered bylight_fuzz_icon
44957200

*this image is generated using AI for illustrative purposes only.

Carysil Limited disclosed that the Reserve Bank of India (RBI) has levied a compounding fee of ₹1,44,000 due to a delay in reporting an overseas investment made by its subsidiary. The order, dated July 6, 2026, was passed under Section 15(1) of the Foreign Exchange Management Act, 1999 (FEMA). The company confirmed that the financial implication is limited to the payment of this fee and that the order does not have a material impact on its financial, operational, or other activities.

The regulatory action stems from a contravention of Regulation 13 of the Foreign Exchange Management (Transfer or Issue of Any Foreign Security) Regulations, 2004. The specific violation involved a delay in reporting the investment made by the company's subsidiary beyond the prescribed time limit. The compounding order was issued by the Foreign Exchange Department of the RBI.

Details of the Compounding Order

The following table outlines the key details of the regulatory order and the nature of the contravention:

Sr. No. Particular Remark / Update
1 Name of the authority Reserve Bank of India, Foreign Exchange Department, Mumbai ("RBI")
2 Nature and details of the action(s) taken or order(s) passed Compounding Order under Section 15(1) of FEMA, 1999, compounding a contravention of Regulation 13 of the Foreign Exchange Management (Transfer or Issue of Any Foreign Security) Regulations, 2004, on account of delay in reporting to RBI, the investment made by the Company's subsidiary. A sum of ₹1,44,000/- (Rupees One Lakh Forty Four Thousand only) has been levied.
3 Date of receipt of direction or order July 06, 2026
4 Details of the violation(s)/contravention(s) committed Delay in reporting to RBI, the investment made by the Company's subsidiary, in contravention of Regulation 13 of the Foreign Exchange Management (Transfer or Issue of Any Foreign Security) Regulations, 2004 (FEMA 120/RB-2004).
5 Impact on financial, operational or other activities The order pertains to a procedural/reporting delay in respect of an overseas investment and does not have any material impact on the financial, operational or other activities of the Company, other than the compounding sum of ₹1,44,000/- payable to RBI.

The disclosure was made to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Reena Shah, Company Secretary & Compliance Officer, signed the disclosure on behalf of Carysil Limited.

Historical Stock Returns for CARYSIL

1 Day5 Days1 Month6 Months1 Year5 Years
+5.73%+6.50%+11.93%+32.06%+57.66%+92.94%

What internal compliance measures will Carysil implement to prevent future reporting delays for overseas investments?

Could this regulatory action influence the company's strategy regarding future foreign expansion or subsidiary investments?

How might investors perceive this procedural lapse in the context of Carysil's overall governance standards?

More News on CARYSIL

Must Read Next

Earnings

Bannari Amman Spinning Mills Q1 Results: Net Profit Rises to 138M Rupees YoY 28 mins ago
no imag found
Wockhardt Q1 Results: Net Profit at 1.06B rupees vs Loss of 900M YoY 45 mins ago
Windlas Biotech Q1 Results: Revenue rises to 2.5B rupees, EBITDA margin contracts to 10.75% YoY 45 mins ago

Stocks

Exicom Tele-Systems Expects Higher EV Sales, Plans to Double AC Line Capacity From Q3 1 hr ago
no imag found
Bharat Forge Co-MD Flags Ongoing Review of Global Manufacturing Strategy Amid Profitability Challenges 1 hr ago
1 Year Returns:+57.66%